Cargando…
Montelukast in Adenoid Hypertrophy: Its Effect on Size and Symptoms
INTRODUCTION: Adenotonsillar hypertrophy (AH) is considered the most common cause of upper respiratory tract obstruction among children. It results in a spectrum of symptoms from mouth breathing, nasal obstruction, hyponasal speech, snoring, and obstructive sleep apnea (OSA) to growth failure and ca...
Autores principales: | Shokouhi, Farshid, Meymaneh Jahromi, Ahmad, Majidi, Mohamad Reza, Salehi, Maryam |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Mashhad University of Medical Sciences
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4706629/ https://www.ncbi.nlm.nih.gov/pubmed/26788489 |
Ejemplares similares
-
Clinical outcome of Montelukast Sodium in Children with Adenoid Hypertrophy
por: Naqi, Syed Ali, et al.
Publicado: (2021) -
Correlation between adenoidal nasopharyngeal ratio and symptoms of enlarged adenoids in children with adenoidal hypertrophy
por: Adedeji, Taiwo Olugbemiga, et al.
Publicado: (2016) -
Reliability of nasofibroscopy for the evaluation of adenoid hypertrophy and its correlation with clinical symptoms
por: Sant’Ana, Juliana Pascutti, et al.
Publicado: (2023) -
Community level evaluation of adenoid hypertrophy on the basis of symptom scoring and its X-ray correlation
por: Dixit, Yogita, et al.
Publicado: (2016) -
Adenoid lymphocyte heterogeneity in pediatric adenoid hypertrophy and obstructive sleep apnea
por: Zhu, Yaxin, et al.
Publicado: (2023)